New research confirms that COVID-19 vaccines are safe and effective at reducing the cardiovascular complications that are a hallmark of COVID-19 infection.
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai AstraZeneca
Menampilkan 1 - 20 dari 26 artikel
For a malaria vaccine to have an impact, health promotion is key. Awareness campaigns must address safety concerns and emphasise expected positive impacts.
On the horizon: A new omicron-focused version of the Moderna vaccine that may offer longer protection and a stronger immune response.
Evusheld is an antibody drug from AstraZeneca intended to help prevent COVID-19 infection for immunocompromised and other vulnerable patients.
Fewer people reported needing to miss work after their booster, compared to their second dose.
There’s not enough evidence yet to support the AstraZeneca CEO’s statement. But it is theoretically plausible.
Paxlovid is one potential COVID drug for use at home. The idea is these can potentially be prescribed at the first sign of infection to prevent serious illness and death.
Protection from infection wanes over time. So boosters will offer extra protection and hopefully reduce the spread of the virus even further.
AstraZeneca’s durable monoclonal antibody treatment has shown promise in phase 3 clinical trials.
Modelling suggested Sydney would open up when NSW had around 1,900 new daily cases. Last Monday, it eased restrictions with just 496 new cases.
There are very few situations where someone can’t have a COVID vaccine for medical reasons.
You’ll read lots of different figures on this — six months, eight months, more — and that’s because the research is ongoing. We don’t yet have a concrete answer.
Thanks to the collaborative efforts of governments, funding agencies, academia, biotech and pharmaceutical companies, large-scale manufacturing of mRNA drug products is becoming a reality.
Most kids will be unvaccinated if schools in the two largest states re-open in term 4. There may still be community transmission, but there are measures we can take to shield kids from the virus.
Each dose of Pfizer has a long and complex path involving mixing, storage at temperatures colder than the South Pole and specific protocols that must be followed before it becomes a jab.
With the reality of the COVID situation in Australia, particularly in New South Wales, some older adults could literally die waiting.
What do you need to weigh up when working out whether to get the AstraZeneca vaccine? Here’s what the evidence says.
What kind of vaccine is Sputnik V, how does it work, and what data are we missing?
If Australians won’t take the AstraZeneca vaccine, we must donate it to save lives elsewhere, especially while we queue-jump for more Pfizer doses.
ATAGI is grappling with competing concerns, considerable uncertainty, and a constantly changing landscape.
Kontributor teratas
-
Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Lecturer, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney
-
Professor of Medical Microbiology, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Adjunct Professional Fellow, CQUniversity Australia
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professorial Fellow, University of Canberra
-
Pro Vice-Chancellor: Climate, Sustainability and Inequality and Director: Southern Centre for Inequality Studies., University of the Witwatersrand
-
Associate Professor of the School of Pharmacy, University of Sydney
-
Associate Professor, Epidemiology, Deakin University
-
Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, University of the Witwatersrand
-
Chair of Social Security Systems Administration and Management Studies, Adjunct Professor in the School of Governance, University of the Witwatersrand
-
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute
-
Infectious Diseases Physician, St Vincent's Hospital, Sydney; Scientia Professor, Kirby Institute, UNSW Sydney
-
Professor of Economics, UNSW Sydney
